英国国民健康服务署推出新皮肤癌疫苗试验, UK's NHS launches trial for a new skin cancer vaccine aiming to boost melanoma treatment.

联合王国的国民保健制度正在开始试验一种称为ISCIB1+的新的皮肤癌疫苗,其目的是提高免疫系统防治黑瘤的能力。 The UK's NHS is launching a trial for a new skin cancer vaccine called iSCIB1+ that aims to enhance the immune system's ability to fight melanoma. 该试验旨在到2030年向多达10,000名病人提供个性化癌症治疗。 Part of the Cancer Vaccine Launch Pad program, the trial seeks to provide up to 10,000 patients with personalized cancer treatments by 2030. 由Scancell研制的疫苗旨在帮助免疫系统更有效地识别和攻击癌症细胞,从而有可能防止癌症复发。 The vaccine, developed by Scancell, is designed to help the immune system recognize and attack cancer cells more effectively, potentially preventing the cancer's return. 预计到10月,审判将招募更多的病人。 The trial is expected to recruit more patients by October.